R-COPADM Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of rituximab plus cyclophosphamide, doxorubicin, methotrexate, prednisone, and vincristine that may be used in the treatment of Burkitt lymphoma and diffuse large B-cell lymphoma (DLBCL).

**Synonyms:** - COPADM Plus Rituximab - Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Rituximab/Vincristine - Cyclophosphamide/Vincristine/Prednisone/Doxorubicin/Methotrexate Plus Rituximab - R-COPADM - R-COPADM - R-COPADM (rituximab-abbs) - R-COPADM (rituximab-arrx) - R-COPADM (rituximab-blit) - R-COPADM (rituximab-pvvr) - R-COPADM (rituximab-rite) - R-COPADM (rituximab-rixa) - R-COPADM (rituximab-rixi) - Rituximab/Cyclophosphamide/Oncovin/Prednisone/Adriamycin/Methotrexate - Rituximab/Cyclophosphamide/Vincristine/Prednisone/Doxorubicin/Methotrexate